A single mega dose of rFVIIa for treatment of hemophilia patients with inhibitors.

被引：0
|
作者：
Kenet, G [1 ]
Lubetsky, A [1 ]
Luboshitz, J [1 ]
Varon, D [1 ]
Martinowitz, U [1 ]
机构：
[1] Chaim Sheba Med Ctr, Natl Hemophilia Ctr, Tel Hashomer, Israel
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1147
引用
收藏
页码：267A / 267A
页数：1
相关论文
共 50 条
  • [31] Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors
    Kenet, Gili
    Martinowitz, Uri
    SEMINARS IN HEMATOLOGY, 2008, 45 (02) : S38 - S41
  • [32] Single-dose management with rFVIIa
    不详
    THROMBOSIS AND HAEMOSTASIS, 2007, 98 (06) : A2 - A4
  • [33] Surgical Experience with Recombinant FVIIa (rFVIIa) in Patients with Hemophilia and Inhibitors to Factors VIII or IX.
    Valentino, Leonard A.
    Cooper, David L.
    BLOOD, 2009, 114 (22) : 534 - 534
  • [34] Secondary prophylaxis with rFVIIa improves quality of life of hemophilia patients with inhibitors and frequent bleeds.
    Konkle, Barbara A.
    Ebbesen, Liselotte S.
    Auerswald, Guenter K. H.
    Friedrich, Ute
    Ljung, Rolf C. R.
    Roberts, Harold R.
    Hoots, W. Keith
    BLOOD, 2006, 108 (11) : 306A - 306A
  • [35] Health economic review of recombinant activated factor VII (Novoseven®) for treatment of bleeding episodes in hemophilia patients with inhibitors.
    Stephens, Jennifer M.
    Botteman, Marc F.
    Joshi, Ashish V.
    Sumner, Michael
    BLOOD, 2006, 108 (11) : 482B - 482B
  • [36] Potential advantages of PAS ports in pediatric patients with hemophilia and high titer inhibitors.
    Heisel, MA
    Nelson, SC
    Osip, JM
    BLOOD, 1995, 86 (10) : 3480 - 3480
  • [37] A comparison of prescribed and actual recombinant factor VIIa (rFVIIa) dosing in pediatric versus adult patients with congenital hemophilia with inhibitors (CHwI): analysis of the dosing observational study in hemophilia (DOSE)
    Gruppo, R.
    Kessler, C.
    Neufeld, E.
    Shapiro, A.
    Cooper, D.
    Carr, M., Jr.
    HAEMOPHILIA, 2010, 16 : 73 - 73
  • [38] Single 270 μg kg-1-dose rFVIIa vs. standard 90 μg kg-1-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors:: a randomized comparison
    Young, G.
    Shafer, F. E.
    Rojas, P.
    Seremetis, S.
    HAEMOPHILIA, 2008, 14 (02) : 287 - 294
  • [39] A single dose of recombinant activated factor VII in mild to moderate bleeds in hemophilia patients with inhibitors
    Almagro, D.
    Agramonte, O.
    Zamora, Y.
    Ballester, J.
    HAEMOPHILIA, 2008, 14 : 22 - 22
  • [40] Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry
    Salaj, Peter
    Kubes, Radovan
    Cetkovsky, Petr
    Capova, Irena
    Penka, Miroslav
    Ovesna, Petra
    Mesterton, Johan
    Lindgren, Peter
    THROMBOSIS RESEARCH, 2014, 133 (02) : 162 - 167
12345